Hill, Mitch C.'s Form 4 filing
Inari Medical, Inc.NARI · filed Mar 14, 2024
- Accession no.
- 0001127602-24-010133
- Filed
- Mar 14, 2024, 4:31 PM ET
- Trade date
- Mar 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $251.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hill, Mitch C.CIK 0001644989 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseAcquired | +6,000 | $0.457 | +$2,742 | 189,361 | Direct | |
| Mar 12, 2024 | Common Stock | SSaleDisposed | −5,999 | $41.91F2 | −$251,418.09 | 183,362 | Direct | |
| Mar 12, 2024 | Common Stock | SSaleDisposed | −1 | $42.58 | −$42.58 | 183,361 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 88,477 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $41.41 to $42.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.